Alpine Associates Management’s Aerie Pharmaceuticals AERI Stock Holding History

Alpine Associates Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,028,900	Closed	-$15.6M	–	48
2022 Q3	$15.6M	Buy	+1,028,900	New	+$12M	0.65%	39

Alpine Associates Management's AERI Position: Q4 2022 in Review

Alpine Associates Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,028,900 shares — an estimated $15.6M sold.

Alpine Associates Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $15.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Alpine Associates Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Alpine Associates Management sold 1,028,900 Aerie Pharmaceuticals shares in Q4 2022, an estimated $15.6M.
Alpine Associates Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Alpine Associates Management's Aerie Pharmaceuticals position peaked at $15.6M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Alpine Associates Management's 13F filing for Q4 2022, filed 8 Feb 2023.